Literature DB >> 16365775

[Fetal lung development on MRT. Normal course and impairment due to premature rupture of membranes].

G Kasprian1, P C Brugger, H Helmer, M Langer, C Balassy, D Prayer.   

Abstract

A well-organized interplay between many molecular factors as well as mechanical forces influence fetal lung development. At the end of this complex process a sufficiently sized and structurally mature organ should ensure the postnatal survival of the newborn. Besides prenatal ultrasonography, magnetic resonance imaging (MRI) can now be used to investigate normal and pathological human lung growth in utero. Oligohydramnios, due to premature rupture of membranes (PROM), is an important risk factor for compromised fetal lung growth. In these situations MR volumetry can be used to measure the size of the fetal lung quite accurately. Together with the evaluation of lung signal intensities on T2-weighted sequences, fetuses with pulmonary hypoplasia can be readily detected.

Entities:  

Mesh:

Year:  2006        PMID: 16365775     DOI: 10.1007/s00117-005-1321-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  28 in total

1.  The changes in magnetic resonance properties of the fetal lungs: a first result and a potential tool for the non-invasive in utero demonstration of fetal lung maturation.

Authors:  K R Duncan; P A Gowland; A Freeman; R Moore; P N Baker; I R Johnson
Journal:  Br J Obstet Gynaecol       Date:  1999-02

2.  Fetal sheep with tracheal occlusion: monitoring lung development with MR imaging and B-mode US.

Authors:  Ulrike Wedegaertner; Mikhail Tchirikov; Christian Habermann; Kurt Hecher; Jan Deprest; Gerhard Adam; Hobe J Schroeder
Journal:  Radiology       Date:  2003-12-29       Impact factor: 11.105

3.  Quantitative and qualitative evaluations of fetal lung with MR imaging.

Authors:  Hisao Osada; Kenshi Kaku; Kentaro Masuda; Yoshinori Iitsuka; Katsuyoshi Seki; Souei Sekiya
Journal:  Radiology       Date:  2004-04-29       Impact factor: 11.105

4.  Fetal lung volumetry by three-dimensional ultrasound.

Authors:  U G Pöhls; A Rempen
Journal:  Ultrasound Obstet Gynecol       Date:  1998-01       Impact factor: 7.299

Review 5.  The fetal lung. 2: Pulmonary hypoplasia.

Authors:  J A Laudy; J W Wladimiroff
Journal:  Ultrasound Obstet Gynecol       Date:  2000-10       Impact factor: 7.299

Review 6.  1976 Edward B.D. Neuhauser lecture: the lung: growth and remodeling in health and disease.

Authors:  L Reid
Journal:  AJR Am J Roentgenol       Date:  1977-11       Impact factor: 3.959

7.  Neonatal pulmonary hypoplasia with premature rupture of fetal membranes and oligohydramnios.

Authors:  D W Thibeault; E C Beatty; R T Hall; S K Bowen; D H O'Neill
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

8.  Human lung growth in late gestation and in the neonate.

Authors:  C Langston; K Kida; M Reed; W M Thurlbeck
Journal:  Am Rev Respir Dis       Date:  1984-04

9.  Postnatal human lung growth.

Authors:  W M Thurlbeck
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139

10.  Fetal thoracic abnormalities: MR imaging.

Authors:  Deborah Levine; Carol E Barnewolt; Tejas S Mehta; Isabelle Trop; Judy Estroff; Geoffrey Wong
Journal:  Radiology       Date:  2003-06-23       Impact factor: 11.105

View more
  2 in total

1.  The Effects of Hemodynamic Alterations on Lung Volumes in Fetuses with Tetralogy of Fallot: An MRI Study.

Authors:  Vanessa Berger-Kulemann; Rudolf Berger; Elisabeth Mlczoch; Daniel Sternal; Mariella Mailath-Pokorny; Nilouparak Hachemian; Daniela Prayer; Michael Weber; Ulrike Salzer-Muhar
Journal:  Pediatr Cardiol       Date:  2015-04-18       Impact factor: 1.655

2.  Foetal lung volumes in pregnant women who deliver very preterm: a pilot study.

Authors:  Lisa Story; Tong Zhang; Johannes K Steinweg; Jana Hutter; Jacqueline Matthew; Theodore Dassios; Paul T Seed; Dharmintra Pasupathy; Joanna Allsop; Joseph V Hajnal; Anne Greenough; Andrew H Shennan; Mary Rutherford
Journal:  Pediatr Res       Date:  2019-12-07       Impact factor: 3.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.